These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32570685)

  • 1. Towards Prediction of Type 1 Diabetes Patients Who Fail to Achieve Glycemic Target.
    Jensen MH; Cichosz S; Hejlesen O; Hirsch IB; Vestergaard P
    Stud Health Technol Inform; 2020 Jun; 270():1413-1414. PubMed ID: 32570685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia.
    van Beers CA; Kleijer SJ; Serné EH; Geelhoed-Duijvestijn PH; Snoek FJ; Kramer MH; Diamant M
    BMC Endocr Disord; 2015 Aug; 15():42. PubMed ID: 26292721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glycemic control in patients with diabetes mellitus on hemodialysis].
    Lobanova KG; Severina AS; Martinov SA; Shamkhalova MS; Shestakova MV
    Ter Arkh; 2019 Oct; 91(10):124-134. PubMed ID: 32598642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of flash glucose monitoring on glycemic control in participants with diabetes mellitus: A meta-analysis of randomized controlled trials.
    Gao Y; Zhou M; Xu X; Chen WY
    J Diabetes Complications; 2022 Nov; 36(11):108314. PubMed ID: 36208566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring and intensive treatment of type 1 diabetes.
    ; Tamborlane WV; Beck RW; Bode BW; Buckingham B; Chase HP; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Hirsch IB; Huang ES; Kollman C; Kowalski AJ; Laffel L; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer S; Wilson DM; Wolpert H; Wysocki T; Xing D
    N Engl J Med; 2008 Oct; 359(14):1464-76. PubMed ID: 18779236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to Letter by Seibold regarding "Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes".
    Oliver N; Avari P; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):697-698. PubMed ID: 32052652
    [No Abstract]   [Full Text] [Related]  

  • 7. Importance of glucose control.
    Edelman SV
    Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes.
    Rodbard HW; Peters AL; Slee A; Cao A; Traina SB; Alba M
    Diabetes Care; 2017 Feb; 40(2):171-180. PubMed ID: 27899497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Jensen MH; Vestergaard P; Hirsch IB; Hejlesen O
    J Diabetes Sci Technol; 2022 Jan; 16(1):106-112. PubMed ID: 32945187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittently Scanned Glucose Values for Continuous Monitoring: Cross-Sectional Analysis of Glycemic Control and Hypoglycemia in 1809 Children and Adolescents with Type 1 Diabetes.
    Biester T; Grimsmann JM; Heidtmann B; Rami-Merhar B; Ermer U; Wolf J; Freff M; Karges B; Agena D; Bramlage P; Danne T; Holl RW
    Diabetes Technol Ther; 2021 Mar; 23(3):160-167. PubMed ID: 33084351
    [No Abstract]   [Full Text] [Related]  

  • 13. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
    Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
    Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Horm Res Paediatr; 2021; 94(9-10):369-373. PubMed ID: 34915493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.
    Polonsky WH; Hessler D; Ruedy KJ; Beck RW;
    Diabetes Care; 2017 Jun; 40(6):736-741. PubMed ID: 28389582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Including Continuous Glucose Monitoring to Provide Personalized Glycemic Profiles as Part of a Pilot Worksite Health Screening.
    Crawford M; Johnson M; Klein IJ; Hames KC; Norman GJ
    J Diabetes Sci Technol; 2021 Mar; 15(2):515-516. PubMed ID: 33095028
    [No Abstract]   [Full Text] [Related]  

  • 18. Machine Learning to Identify Predictors of Glycemic Control in Type 2 Diabetes: An Analysis of Target HbA1c Reduction Using Empagliflozin/Linagliptin Data.
    Del Parigi A; Tang W; Liu D; Lee C; Pratley R
    Pharmaceut Med; 2019 Jun; 33(3):209-217. PubMed ID: 31933292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
    Rossetti P; Ampudia-Blasco FJ; Laguna A; Revert A; Vehì J; Ascaso JF; Bondia J
    Diabetes Technol Ther; 2012 Nov; 14(11):1043-52. PubMed ID: 23003329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
    Billings LK; Parkin CG; Price D
    Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.